Your browser doesn't support javascript.
loading
Contrast-Enhanced Mammography-Guided Breast Biopsy: Single-Center Experience.
Kornecki, Anat; Bhaduri, Mousumi; Khan, Nasir; Nachum, Ilanit Ben; Muscedere, Giulio; Shmuilovich, Olga; Lynn, Kalan; Nano, Eni; Blyth, Lily.
Afiliación
  • Kornecki A; Department of Medical Imaging, St. Joseph's Health Care London, 268 Grosvenor St, Rm C0-251, London, ON N6V 4V2, Canada.
  • Bhaduri M; Department of Medical Imaging, London Health Sciences Centre, London, ON, Canada.
  • Khan N; Department of Medical Imaging, Grand River Hospital, Kitchener, ON, Canada.
  • Nachum IB; Department of Medical Imaging, St. Joseph's Health Care London, 268 Grosvenor St, Rm C0-251, London, ON N6V 4V2, Canada.
  • Muscedere G; Department of Medical Imaging, St. Joseph's Health Care London, 268 Grosvenor St, Rm C0-251, London, ON N6V 4V2, Canada.
  • Shmuilovich O; Department of Medical Imaging, St. Joseph's Health Care London, 268 Grosvenor St, Rm C0-251, London, ON N6V 4V2, Canada.
  • Lynn K; Department of Medical Imaging, St. Joseph's Health Care London, 268 Grosvenor St, Rm C0-251, London, ON N6V 4V2, Canada.
  • Nano E; Department of Medical Imaging, St. Joseph's Health Care London, 268 Grosvenor St, Rm C0-251, London, ON N6V 4V2, Canada.
  • Blyth L; Department of Health Sciences, Wilfrid Laurier University, Waterloo, ON, Canada.
AJR Am J Roentgenol ; 220(6): 826-827, 2023 06.
Article en En | MEDLINE | ID: mdl-36722757
This prospective single-center study enrolled 50 women with 51 contrast-enhanced mammography (CEM)-enhancing lesions that lacked a sonographic or mammographic correlate. Trial participants underwent CEM-guided biopsy. Biopsy was technically successful for 46 lesions and was not performed for five nonvisualized lesions (all nonmass enhancement), yielding a cancellation rate of 9.8%. Mean biopsy time was 16.6 minutes. All biopsies revealed concordant pathology (25 benign, 10 high-risk, 11 malignant). No non-visualized or benign lesion yielded malignancy at follow-up.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mama / Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: AJR Am J Roentgenol Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mama / Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: AJR Am J Roentgenol Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos